|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-3-28
|
|
pubmed:abstractText |
The role of positron emission tomography (PET) with 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) is currently under evaluation in urologic oncology. The aim of the present study was to investigate the use of [18F]FDG positron emission tomography ([18F]FDG-PET) in the detection and treatment control of malignant germ cell tumors compared to computed tomography (CT).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0042-1138
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 S. Karger AG, Basel
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
157-63
|
|
pubmed:dateRevised |
2006-10-30
|
|
pubmed:meshHeading |
pubmed-meshheading:11919460-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11919460-Cisplatin,
pubmed-meshheading:11919460-Fluorodeoxyglucose F18,
pubmed-meshheading:11919460-Germinoma,
pubmed-meshheading:11919460-Humans,
pubmed-meshheading:11919460-Male,
pubmed-meshheading:11919460-Predictive Value of Tests,
pubmed-meshheading:11919460-Radiopharmaceuticals,
pubmed-meshheading:11919460-Sensitivity and Specificity,
pubmed-meshheading:11919460-Testicular Neoplasms,
pubmed-meshheading:11919460-Tomography, Emission-Computed,
pubmed-meshheading:11919460-Tomography, X-Ray Computed
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors.
|
|
pubmed:affiliation |
Department of Urology, University of Dresden, Germany.
|
|
pubmed:publicationType |
Journal Article
|
